http://venturebeat.com/2007/10/18/life-sciences-briefing-thursday-oct-18-2007/ News About Tech, Money and Innovation Tue, 24 Nov 2009 05:47:06 +0000 http://wordpress.org/?v=2.8.5 hourly 1 http://venturebeat.com/2007/10/18/life-sciences-briefing-thursday-oct-18-2007/comment-page-1/#comment-608806 VentureBeat » Life sciences briefing: Thursday, Nov. 1, 2007 Thu, 01 Nov 2007 11:15:37 +0000 http://venturebeat.com/2007/10/18/life-sciences-briefing-thursday-oct-18-2007/#comment-608806 [...] patient’s likely response to a particular medication. Our previous coverage of the company is here and [...] [...] patient’s likely response to a particular medication. Our previous coverage of the company is here and [...]

]]> http://venturebeat.com/2007/10/18/life-sciences-briefing-thursday-oct-18-2007/comment-page-1/#comment-600000 VentureBeat » IPO roundup: Bioheart, Merrion Pharma in limbo; Reliant vs. Reliant road shows; upcoming offerings Mon, 29 Oct 2007 00:40:09 +0000 http://venturebeat.com/2007/10/18/life-sciences-briefing-thursday-oct-18-2007/#comment-600000 [...] (our coverage) For more stories on VentureBeat Life Sciences, click here.Tagged co:Akela Pharma, co:Bioheart, [...] [...] (our coverage) For more stories on VentureBeat Life Sciences, click here.Tagged co:Akela Pharma, co:Bioheart, [...]

]]>